$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC

2018 Q3 Form 10-Q Financial Statement

#000107997318000607 Filed on November 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3 2016 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $680.0K $310.0K $530.0K
YoY Change 119.35% -26.19% -3.64%
% of Gross Profit
Research & Development $169.7K $106.7K $126.1K
YoY Change 59.0% -4.9% 49.59%
% of Gross Profit
Depreciation & Amortization $436.00 $436.00 $503.00
YoY Change 0.0% -13.15% -99.34%
% of Gross Profit
Operating Expenses $848.0K $419.3K $653.3K
YoY Change 102.25% -21.98% -8.05%
Operating Profit -$848.0K -$419.3K -$653.3K
YoY Change 102.25% -21.98% -8.05%
Interest Expense $92.50K $98.44K $94.57K
YoY Change -6.04% 6.12% 8.81%
% of Operating Profit
Other Income/Expense, Net -$92.50K -$98.44K -$94.57K
YoY Change -6.04% 6.12% 8.81%
Pretax Income -$940.0K -$520.0K -$750.0K
YoY Change 80.77% -17.46% -6.25%
Income Tax
% Of Pretax Income
Net Earnings -$940.5K -$517.7K -$747.8K
YoY Change 81.66% -17.85% -6.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$36.63K -$21.60K -$32.15K
COMMON SHARES
Basic Shares Outstanding 25.66M 24.07M 23.33M
Diluted Shares Outstanding 25.66M

Balance Sheet

Concept 2018 Q3 2017 Q3 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $180.0K $0.00 $10.00K
YoY Change -100.0% -94.44%
Cash & Equivalents $176.4K $2.413K $72.93K
Short-Term Investments
Other Short-Term Assets $10.00K $0.00 $10.00K
YoY Change -100.0% -50.0%
Inventory
Prepaid Expenses $11.01K $2.856K $8.201K
Receivables
Other Receivables $1.000K $2.380K $1.180K
Total Short-Term Assets $188.4K $7.649K $17.02K
YoY Change 2363.41% -90.59% -92.69%
LONG-TERM ASSETS
Property, Plant & Equipment $1.012K $2.756K $3.254K
YoY Change -63.28% -26.64% -99.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.012K $2.756K $3.254K
YoY Change -63.28% -26.64% -99.82%
TOTAL ASSETS
Total Short-Term Assets $188.4K $7.649K $17.02K
Total Long-Term Assets $1.012K $2.756K $3.254K
Total Assets $189.4K $10.41K $20.27K
YoY Change 1720.64% -87.77% -99.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $640.0K $920.0K $870.0K
YoY Change -30.43% 12.2% -41.22%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $110.0K $3.340M
YoY Change -100.0%
Long-Term Debt Due $9.090M $8.850M $8.680M
YoY Change 2.71% 2.67% 12.0%
Total Short-Term Liabilities $10.29M $12.24M $14.80M
YoY Change -15.95% 10.06% 41.87%
LONG-TERM LIABILITIES
Long-Term Debt $3.560M $3.350M $0.00
YoY Change 6.27% 1.21% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.560M $3.350M $0.00
YoY Change 6.27% 1.21% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.29M $12.24M $14.80M
Total Long-Term Liabilities $3.560M $3.350M $0.00
Total Liabilities $13.85M $15.65M $14.80M
YoY Change -11.52% 8.4% 8.41%
SHAREHOLDERS EQUITY
Retained Earnings -$122.6M -$119.2M -$117.6M
YoY Change 2.88% 2.01% 3.77%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.71M -$15.64M -$14.84M
YoY Change
Total Liabilities & Shareholders Equity $189.4K $10.41K $20.27K
YoY Change 1720.64% -87.77% -99.02%

Cashflow Statement

Concept 2018 Q3 2017 Q3 2016 Q4
OPERATING ACTIVITIES
Net Income -$940.5K -$517.7K -$747.8K
YoY Change 81.66% -17.85% -6.0%
Depreciation, Depletion And Amortization $436.00 $436.00 $503.00
YoY Change 0.0% -13.15% -99.34%
Cash From Operating Activities -$223.7K -$125.6K -$70.00K
YoY Change 78.07% -44.44% -61.11%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 378.1K 55.11K 10.00K
YoY Change 586.13% -54.21% -94.12%
NET CHANGE
Cash From Operating Activities -223.7K -125.6K -70.00K
Cash From Investing Activities 0.000
Cash From Financing Activities 378.1K 55.11K 10.00K
Net Change In Cash 154.4K -70.52K -60.00K
YoY Change -318.95% -33.33% 500.0%
FREE CASH FLOW
Cash From Operating Activities -$223.7K -$125.6K -$70.00K
Capital Expenditures $0.00
Free Cash Flow -$125.6K -$70.00K
YoY Change -44.44% -61.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 bnet Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
166776
CY2018Q3 bnet Adjustment To Additional Paid In Capital Modification Ofoptions
AdjustmentToAdditionalPaidInCapitalModificationOfoptions
222300
CY2018Q3 bnet Class Of Warrant Or Right Number For Which Expiration Date Extended
ClassOfWarrantOrRightNumberForWhichExpirationDateExtended
5079188
CY2018 bnet Common Stock Voting Rights Votes Per Share
CommonStockVotingRightsVotesPerShare
1
CY2018Q3 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
171613
CY2018Q2 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
171613
bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
100000
bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
CY2018Q3 bnet Deferred Compensation Consecutive Trading Days
DeferredCompensationConsecutiveTradingDays
P10D
CY2018Q3 bnet Deferred Compensation Conversion Days
DeferredCompensationConversionDays
P5D
CY2018 bnet Deferred Compensation Liability Amount Cancelled
DeferredCompensationLiabilityAmountCancelled
2404000
CY2013Q2 bnet Extension Of Exercise Period Annual Payment Per Option Or Warrant
ExtensionOfExercisePeriodAnnualPaymentPerOptionOrWarrant
0.05
CY2018Q3 bnet Interest Expense Related To The Modification Of Warrants
InterestExpenseRelatedToTheModificationOfWarrants
3750
CY2018Q3 bnet Interest Rate On Deferred Compensation
InterestRateOnDeferredCompensation
0.04
CY2018Q3 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9091113
CY2018Q2 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9028983
CY2018Q3 bnet Modification Of Warrants
ModificationOfWarrants
163026
bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
416999
bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
39312
CY2018Q3 bnet Sale Of Units Value
SaleOfUnitsValue
416999
CY2018Q2 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2017Q2 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2018Q3 bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
514
bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
514
bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
CY2018Q3 bnet Stock Issued During Period Shares Commissions On Sale Of Units
StockIssuedDuringPeriodSharesCommissionsOnSaleOfUnits
1028
CY2018Q3 bnet Stock Issued During Period Value Commissions On Sale Of Units
StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits
38900
bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
330000
bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
CY2018Q3 bnet Weighted Average Exercise Price For Outstanding Warrants
WeightedAverageExercisePriceForOutstandingWarrants
0.96
CY2018Q3 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
424147
CY2017Q3 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
23189
CY2018Q3 bnet Weighted Average Remaining Contractual Life For Outstanding Warrants
WeightedAverageRemainingContractualLifeForOutstandingWarrants
P4Y146D
CY2018Q3 bnet Working Capital
WorkingCapital
-10103000
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
644428
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
719633
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2794741
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2794305
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
109424707
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108117330
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
95500
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3750
CY2018Q3 us-gaap Assets
Assets
189438
CY2018Q2 us-gaap Assets
Assets
31935
CY2018Q3 us-gaap Assets Current
AssetsCurrent
188426
CY2018Q2 us-gaap Assets Current
AssetsCurrent
30487
CY2018Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2018Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22013
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72932
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
176412
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2413
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22013
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
154399
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-70519
CY2018Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16100000
CY2018Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
504650
CY2018Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
174650
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26996148
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25939892
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24748213
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26291839
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25235583
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24043904
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
CY2018Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>exceed federally insured limits. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any losses on such accounts.</div></div></div></div></div></div></div></div></div>
CY2009Q1 us-gaap Construction Loan
ConstructionLoan
7750000
CY2018Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3556473
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3525216
CY2018Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
523628
CY2017Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2328287
CY2018Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
421641
CY2018Q3 us-gaap Depreciation
Depreciation
436
CY2017Q3 us-gaap Depreciation
Depreciation
436
us-gaap Depreciation
Depreciation
436
us-gaap Depreciation
Depreciation
436
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
45000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
677890
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
312117
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1684562
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62268
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
56339
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
185400
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
203400
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3540
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3570
CY2018Q3 us-gaap Interest Expense
InterestExpense
92496
CY2017Q3 us-gaap Interest Expense
InterestExpense
98439
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2018Q3 us-gaap Liabilities
Liabilities
13847542
CY2018Q2 us-gaap Liabilities
Liabilities
13726873
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
189438
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31935
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10291069
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10201657
CY2018Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2018Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2018Q3 us-gaap Minority Interest
MinorityInterest
51169
CY2018Q2 us-gaap Minority Interest
MinorityInterest
54338
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
378099
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55106
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-223700
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-125625
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3169
CY2017Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-507
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-937374
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-517231
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-92496
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-98439
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
848047
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
419299
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-848047
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-419299
CY2018Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
417000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19500
CY2018 us-gaap Profit Loss
ProfitLoss
-3018000
CY2017 us-gaap Profit Loss
ProfitLoss
-2463000
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-940543
us-gaap Other Noncash Expense
OtherNoncashExpense
97537
us-gaap Other Noncash Expense
OtherNoncashExpense
107231
CY2018Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
CY2018Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
CY2018Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
39000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
38900
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3706
CY2018Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11014
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7474
CY2018 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
418000
CY2017 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
452000
us-gaap Profit Loss
ProfitLoss
-940543
us-gaap Profit Loss
ProfitLoss
-517738
CY2017Q3 us-gaap Profit Loss
ProfitLoss
-517738
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2795753
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2795753
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1012
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1448
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
169721
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
106746
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122629330
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121691956
CY2018Q3 us-gaap Revenues
Revenues
CY2017Q3 us-gaap Revenues
Revenues
us-gaap Share Based Compensation
ShareBasedCompensation
499278
us-gaap Share Based Compensation
ShareBasedCompensation
21137
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7002225
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.11
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
325000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.36
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6827225
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7152225
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.11
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.10
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.68
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y292D
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
150000
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.25
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y292D
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y292D
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
80500
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
175000
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.46
CY2018Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2018Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
100000
CY2018Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10952
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-13709273
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13749276
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13694938
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13658104
CY2018Q3 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of estimates:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In preparing the Company&#x2019;s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div>
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25659730
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24067093
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25659730
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24067093

Files In Submission

Name View Source Status
0001079973-18-000607-index-headers.html Edgar Link pending
0001079973-18-000607-index.html Edgar Link pending
0001079973-18-000607.txt Edgar Link pending
0001079973-18-000607-xbrl.zip Edgar Link pending
bion_10q-093018.htm Edgar Link pending
bnet-20180930.xml Edgar Link completed
bnet-20180930.xsd Edgar Link pending
bnet-20180930_cal.xml Edgar Link unprocessable
bnet-20180930_def.xml Edgar Link unprocessable
bnet-20180930_lab.xml Edgar Link unprocessable
bnet-20180930_pre.xml Edgar Link unprocessable
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending